Deoxyspergualin

DB12991InvestigationalSmall molecule

Deoxyspergualin has been used in trials studying the treatment of Lupus Nephritis, Chronic Rejection, and Diabetes Mellitus, Type 1.

Chemical structure of Deoxyspergualin
Mechanism
Curator reviewed
Formula / weight
C17H37N7O3 · 387.529 g/mol (avg)
Also known as
(-)-Gusperimus · 15-Desoxyspergualin

Resolves to

Compound
UNII57F9XM233RCAS89149-10-0ChEMBLCHEMBL1172736PubChem91272
Structure
InChIKeyIDINUJSAMVOPCM-INIZCTEOSA-NSMILESNCCCNCCCCNC(=O)[C@H](O)NC(=O)CCCCCCNC(N)=N
Targets
P07900HSP90AA1P49366DHPSP08238HSP90AB1P11142HSPA8P0DMV8HSPA1A

What you can answer from here — as of July 07, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
400Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
14+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Deoxyspergualin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In